1. Home
  2. CERT vs TWST Comparison

CERT vs TWST Comparison

Compare CERT & TWST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CERT
  • TWST
  • Stock Information
  • Founded
  • CERT 2008
  • TWST 2013
  • Country
  • CERT United States
  • TWST United States
  • Employees
  • CERT N/A
  • TWST N/A
  • Industry
  • CERT Retail: Computer Software & Peripheral Equipment
  • TWST Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • CERT Technology
  • TWST Health Care
  • Exchange
  • CERT Nasdaq
  • TWST Nasdaq
  • Market Cap
  • CERT 1.7B
  • TWST 1.8B
  • IPO Year
  • CERT 2020
  • TWST 2018
  • Fundamental
  • Price
  • CERT $11.70
  • TWST $36.79
  • Analyst Decision
  • CERT Buy
  • TWST Buy
  • Analyst Count
  • CERT 6
  • TWST 10
  • Target Price
  • CERT $15.60
  • TWST $49.10
  • AVG Volume (30 Days)
  • CERT 2.0M
  • TWST 1.1M
  • Earning Date
  • CERT 08-05-2025
  • TWST 08-01-2025
  • Dividend Yield
  • CERT N/A
  • TWST N/A
  • EPS Growth
  • CERT N/A
  • TWST N/A
  • EPS
  • CERT N/A
  • TWST N/A
  • Revenue
  • CERT $394,498,000.00
  • TWST $347,680,000.00
  • Revenue This Year
  • CERT $11.57
  • TWST $22.58
  • Revenue Next Year
  • CERT $8.93
  • TWST $17.71
  • P/E Ratio
  • CERT N/A
  • TWST N/A
  • Revenue Growth
  • CERT 9.37
  • TWST 25.30
  • 52 Week Low
  • CERT $8.64
  • TWST $27.12
  • 52 Week High
  • CERT $16.93
  • TWST $60.90
  • Technical
  • Relative Strength Index (RSI)
  • CERT 55.84
  • TWST 60.01
  • Support Level
  • CERT $10.23
  • TWST $35.13
  • Resistance Level
  • CERT $12.41
  • TWST $37.72
  • Average True Range (ATR)
  • CERT 0.50
  • TWST 1.79
  • MACD
  • CERT 0.09
  • TWST 0.39
  • Stochastic Oscillator
  • CERT 67.40
  • TWST 83.48

About CERT Certara Inc.

Certara Inc accelerates medicines to patients using biosimulation software and technology to transform traditional drug discovery and development. It provides modeling and simulation, regulatory science, and assessment software and services to help clients reduce clinical trials, accelerate regulatory approval and increase patient access to medicines. The company has its business presence in the Americas which is also it key revenue generating market, EMEA and Asia Pacific region.

About TWST Twist Bioscience Corporation

Twist Bioscience Corp is a synthetic biology company. It develops a disruptive DNA synthesis platform to industrialize the engineering of biology. The company's DNA synthesis platform utilizes a proprietary semiconductor-based synthetic DNA manufacturing process that synthesizes DNA on silicon instead of on traditional well-plastic plates to enable the production of high-quality synthetic DNA faster and affordable as well as overcomes inefficiencies and powers cost-effective, rapid high-throughput synthesis, enabling researchers to realize opportunities ahead rapidly. Geographically, it derives a majority of its revenue from the United States.

Share on Social Networks: